Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a post on LinkedIn:
“Today at the TTOD 2025 Congress, I had the privilege of listening to Prof. Özlem Türeci speak about the impact of mRNA technology in non-solid tumors and its promising potential in cancer treatment. Hearing these groundbreaking insights directly from one of the pioneers in the field was truly inspiring.”
More posts featuring Elvina Almuradova.